GSK
787 hedge funds and large institutions have $11.1B invested in GSK in 2018 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 224 increasing their positions, 309 reducing their positions, and 50 closing their positions.
Holders
787
Holders Change
+10
Holders Change %
+1.29%
% of All Funds
18.04%
Holding in Top 10
14
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-6.67%
% of All Funds
0.32%
New
66
Increased
224
Reduced
309
Closed
50
Calls
$145M
Puts
$80.5M
Net Calls
+$64.7M
Net Calls Change
+$99.7M
Top Buyers
| 1 |
1
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$81.5M |
| 2 |
2
Jane Street
New York
|
$64.4M |
| 3 |
3
Renaissance Technologies
New York
|
$376M |
| 4 |
EVM
4
Eaton Vance Management
Boston,
Massachusetts
|
$51.7M |
| 5 |
5
Morgan Stanley
New York
|
$146M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CG
851
Cutler Group
San Francisco,
California
| – | – | – | – |
|
852
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
853
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
|
HT
854
HAP Trading
New York
| – | – | – | – |
|
|
PG
855
PEAK6 Group
Chicago,
Illinois
| – | – | – | – |
|
|
BCPEM
856
Bain Capital Public Equity Management
Boston,
Massachusetts
| – | – | – | – |
|
857
Balyasny Asset Management
Chicago,
Illinois
| – | – | – | – |
|